US 12,227,806 B2
Methods for detecting an increased risk for coronary heart disease
Jonathan C. Cohen, Dallas, TX (US); and Helen H. Hobbs, Dallas, TX (US)
Assigned to Board of Regents, The University of Texas System, Austin, TX (US)
Filed by Board of Regents, The University of Texas System, Dallas, TX (US)
Filed on Sep. 13, 2021, as Appl. No. 17/472,740.
Application 17/472,740 is a continuation of application No. 15/810,059, filed on Nov. 11, 2017, abandoned.
Application 15/810,059 is a continuation of application No. 13/907,923, filed on Jun. 2, 2013, abandoned.
Application 13/907,923 is a continuation of application No. 12/151,275, filed on May 2, 2008, abandoned.
Claims priority of provisional application 60/927,361, filed on May 2, 2007.
Prior Publication US 2022/0177969 A1, Jun. 9, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C12Q 1/68 (2018.01); C12Q 1/6883 (2018.01)
CPC C12Q 1/6883 (2013.01) [C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/172 (2013.01)] 4 Claims
 
1. A method for reducing risk of coronary atherosclerosis in a human, the method comprising:
a) determining a human has a ‘G’ allele or its complement at the polymorphic position defined by rs10757274; and
b) administering to the human a therapy to delay the onset, prevent the onset or slow the progression of the coronary atherosclerosis.